Radiation oncologists demonstrate in an early clinical trial that the radiation beam can be carefully “sculpted” to deliver the majority of a dose directly to the tumor while effectively sparing tissues in the side of the esophagus away from the affected lung.
Departments, Centers, & Programs:
Clark Center for Radiation Oncology
100 Blossom Street
Boston, MA 02114-2606
- MD, Yale University School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Harvard Medical School
American Board Certifications
- Radiation Oncology, American Board of Radiology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
View my most recent research: http://www.ncbi.nlm.nih.gov/pubmed/?term=keane%2C+florence+k
Dr. Keane's research focuses on the combination of radiotherapy with systemic therapy, including immunotherapy and targeted therapies.
Dr. Keane is the site Principal Investigator for a Randomized Trial of SBRT with or without Pembrolizumab in patients with early-stage lung cancer. More information can be found at : https://clinicaltrials.gov/ct2/show/NCT03924869?term=SBRT+pembrolizumab&cond=Lung+Cancer+Stage+I&draw=2&rank=1